Filtered By:
Management: Insurance
Vaccination: Pneomococcal Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 104 results found since Jan 2013.
Pneumonia hospitalization after introduction of pneumococcal conjugate vaccine in Japan: Descriptive study using a nationwide claims database
CONCLUSION: Our study estimated 4-6 pneumonia hospitalizations per 1000 pediatric population in Japan, with a 34 % decrease after the introduction of PCV. This study examined the nationwide effectiveness of PCV, further studies are needed in all age groups.PMID:37286407 | DOI:10.1016/j.vaccine.2023.05.065
Source: Vaccine - June 7, 2023 Category: Allergy & Immunology Authors: Takanori Yanai Satomi Yoshida Masato Takeuchi Koji Kawakami Source Type: research
Pneumococcal vaccination coverage at the initiation of chronic dialysis, and its association with mortality during the first year
CONCLUSIONS: Pneumococcal immunization with PCV13 followed by PPSV23, or with PCV13 alone, but not with PPSV23 alone, is independently associated with decreased one year-mortality in patients who start dialysis.PMID:37179164 | DOI:10.1016/j.vaccine.2023.05.003
Source: Vaccine - May 13, 2023 Category: Allergy & Immunology Authors: Élodie Pierre Ad élaïde Pladys Sahar Bayat-Makoei Pierre Tattevin C écile Vigneau Source Type: research
Hospitalizations for infections in primary Sj ögren's syndrome patients: a nationwide incidence study
CONCLUSIONS: pSS patients are at higher risk of hospitalization for infections. The increased risk of hospitalization for mycobacterial infections illustrates the potential bilateral relationship between the two conditions. Vaccination against respiratory pathogens and herpes zoster virus may help prevent some hospitalizations in pSS patients.KEY MESSAGESPrimary Sjögren's syndrome (pSS) increases hospitalization risk for community infections: bronchopulmonary, skin, dental, ear-nose-throat, intestinal infections and pyelonephritis.Hospitalizations for zoster and mycobacterial infections are also increased in this populati...
Source: Herpes - September 29, 2022 Category: Infectious Diseases Authors: Radjiv Goulabchand Alain Makinson Jacques Morel Philine Witkowski-Durand-Viel Nicolas Nagot Paul Loubet Camille Roubille Dani èle Noel David Morquin Kim Henry Thibault Mura Philippe Guilpain Source Type: research
Impacts of Catch-Up Immunization program with the 13-Valent pneumococcal Conjugate vaccine in Taiwan: Focus on age-stratified differences and high-risk population (2001-2015)
CONCLUSIONS: Our study suggests that the introduction of this catch-up program with PCV13 was associated with significant declines in the incidence of pneumococcal pneumonia and all-cause pneumonia in vaccinated children, and indirect protection from the program was also found in unvaccinated children.PMID:36127209 | DOI:10.1016/j.vaccine.2022.09.002
Source: Vaccine - September 20, 2022 Category: Allergy & Immunology Authors: Shih-Tsung Huang Yhu-Chering Huang Edward Kuo Ya-Min Yang Fei-Yuan Hsiao Source Type: research
Development and application of a Japanese vaccine database for comparative assessments in the post-authorization phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
CONCLUSIONS: The VENUS Study is Japan's first healthcare data platform that enables comparative assessments of vaccinated and unvaccinated persons in large samples covering all age groups. Efforts are underway to increase the number of participating municipalities and to generate evidence on vaccine effectiveness and safety.PMID:36096969 | DOI:10.1016/j.vaccine.2022.08.069
Source: Vaccine - September 12, 2022 Category: Allergy & Immunology Authors: Chieko Ishiguro Wataru Mimura Fumiko Murata Haruhisa Fukuda Source Type: research
Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study
CONCLUSION: Pneumococcal and influenza vaccination coverage of adults at risk of pneumococcal disease fell well below public health expectations. Invitations for pneumococcal vaccination should be sent by the NHI to high-risk patients. Patient management protocols should include pneumococcal vaccination. Patients with multiple comorbidities are a high-priority population given the large potential health gains offered by pneumococcal vaccination. Commitment of both scientific societies and health authorities is urgently needed to increase vaccination coverage in at-risk populations.PMID:35811205 | DOI:10.1016/j.vaccine.2022.06.071
Source: Vaccine - July 10, 2022 Category: Allergy & Immunology Authors: Benjamin Wyplosz J érôme Fernandes Ariane Sultan Nicolas Roche Fran çois Roubille Paul Loubet Bertrand Foug ère Bruno Moulin Didier Duhot Alexandre Vainchtock Fanny Raguideau Joannie Lortet-Tieulent Emmanuelle Blanc Jennifer Mo ïsi Gwena ël Goussiau Source Type: research
Impact of pneumococcal conjugate vaccination on hospitalized childhood pneumonia in Taiwan
CONCLUSIONS: Pneumococcal parapneumonic diseases and the disease burden of lobar/pneumococcal pneumonia and lower respiratory tract infections declined after the national PCV13 vaccination program.IMPACT: The impact study of the PCV13 immunization program on childhood pneumonia in Asian countries remained limited. The unique PCV13 immunization program in Taiwan, catch-up before primary infantile series, reduced severe childhood pneumococcal pneumonia at 5 years post PCV13. The intensive and invasive medical needs and fatality of all-cause pneumonia decreased significantly in children of all ages. We observed an increase in...
Source: Pediatric Research - December 23, 2021 Category: Pediatrics Authors: Jian-Te Lee Jou-Wei Lin Ho-Min Chen Chen-Yu Wang Chun-Yi Lu Luan-Yin Chang Li-Min Huang Source Type: research
Incidence trends of parapneumonic pleural effusions/empyema in children 2009 to 2018 from health insurance data: Only temporal reduction after the introduction of PCV13
DISCUSSION: We found a nonlinear temporal trend of PPE/PE incidence in children with a decrease from 2009 to 2013 and a subsequent increase until 2018. The former might be explained by a quasi elimination of serotype 1, the latter by an increase in the proportion of serotype 3 as demonstrated in German surveillance data of pediatric PPE/PE cases generated during the same observation period.PMID:34006409 | DOI:10.1016/j.vaccine.2021.05.005
Source: Vaccine - May 19, 2021 Category: Allergy & Immunology Authors: Anna-Lisa Sorg Viola Obermeier Johannes G Liese R üdiger von Kries Source Type: research
Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018
MMWR Surveill Summ. 2021 May 14;70(3):1-26. doi: 10.15585/mmwr.ss7003a1.ABSTRACTPROBLEM/CONDITION: Adults are at risk for illness, hospitalization, disability and, in some cases, death from vaccine-preventable diseases, particularly influenza and pneumococcal disease. CDC recommends vaccinations for adults on the basis of age, health conditions, prior vaccinations, and other considerations. Updated vaccination recommendations from CDC are published annually in the U.S. Adult Immunization Schedule. Despite longstanding recommendations for use of many vaccines, vaccination coverage among U.S. adults remains low.REPORTING PER...
Source: MMWR Surveill Summ - May 13, 2021 Category: Epidemiology Authors: Peng-Jun Lu Mei-Chuan Hung Anup Srivastav Lisa A Grohskopf Miwako Kobayashi Aaron M Harris Kathleen L Dooling Lauri E Markowitz Alfonso Rodriguez-Lainz Walter W Williams Source Type: research
